These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12010908)

  • 41. Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition.
    Lim HW; De Windt LJ; Mante J; Kimball TR; Witt SA; Sussman MA; Molkentin JD
    J Mol Cell Cardiol; 2000 Apr; 32(4):697-709. PubMed ID: 10756124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Leptin-induced cardiomyocyte hypertrophy reveals both calcium-dependent and calcium-independent/RhoA-dependent calcineurin activation and NFAT nuclear translocation.
    Rajapurohitam V; Izaddoustdar F; Martinez-Abundis E; Karmazyn M
    Cell Signal; 2012 Dec; 24(12):2283-90. PubMed ID: 22917533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro.
    Pu WT; Ma Q; Izumo S
    Circ Res; 2003 Apr; 92(7):725-31. PubMed ID: 12663489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+/calmodulin-dependent protein kinase II signaling.
    Bisserier M; Berthouze-Duquesnes M; Breckler M; Tortosa F; Fazal L; de Régibus A; Laurent AC; Varin A; Lucas A; Branchereau M; Marck P; Schickel JN; Deloménie C; Cazorla O; Soulas-Sprauel P; Crozatier B; Morel E; Heymes C; Lezoualc'h F
    Circulation; 2015 Jan; 131(4):390-400; discussion 400. PubMed ID: 25369805
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiac-Specific EPI64C Blunts Pressure Overload-Induced Cardiac Hypertrophy.
    Zhu X; Fang J; Gong J; Guo JH; Zhao GN; Ji YX; Liu HY; Wei X; Li H
    Hypertension; 2016 May; 67(5):866-77. PubMed ID: 27021007
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of cardiac hypertrophy in mice by calcineurin inhibition.
    Sussman MA; Lim HW; Gude N; Taigen T; Olson EN; Robbins J; Colbert MC; Gualberto A; Wieczorek DF; Molkentin JD
    Science; 1998 Sep; 281(5383):1690-3. PubMed ID: 9733519
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway.
    Semsarian C; Wu MJ; Ju YK; Marciniec T; Yeoh T; Allen DG; Harvey RP; Graham RM
    Nature; 1999 Aug; 400(6744):576-81. PubMed ID: 10448861
    [TBL] [Abstract][Full Text] [Related]  

  • 48. c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling.
    Liang Q; Bueno OF; Wilkins BJ; Kuan CY; Xia Y; Molkentin JD
    EMBO J; 2003 Oct; 22(19):5079-89. PubMed ID: 14517246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
    Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
    Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. AT2 receptor activation regulates myocardial eNOS expression via the calcineurin-NF-AT pathway.
    Ritter O; Schuh K; Brede M; Röthlein N; Burkard N; Hein L; Neyses L
    FASEB J; 2003 Feb; 17(2):283-5. PubMed ID: 12490546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TRPC4α and TRPC4β Similarly Affect Neonatal Cardiomyocyte Survival during Chronic GPCR Stimulation.
    Kirschmer N; Bandleon S; von Ehrlich-Treuenstätt V; Hartmann S; Schaaf A; Lamprecht AK; Miranda-Laferte E; Langsenlehner T; Ritter O; Eder P
    PLoS One; 2016; 11(12):e0168446. PubMed ID: 27992507
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multifarious molecular signaling cascades of cardiac hypertrophy: can the muddy waters be cleared?
    Balakumar P; Jagadeesh G
    Pharmacol Res; 2010 Nov; 62(5):365-83. PubMed ID: 20643208
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CIB1 is a regulator of pathological cardiac hypertrophy.
    Heineke J; Auger-Messier M; Correll RN; Xu J; Benard MJ; Yuan W; Drexler H; Parise LV; Molkentin JD
    Nat Med; 2010 Aug; 16(8):872-9. PubMed ID: 20639889
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parsing good versus bad signaling pathways in the heart: role of calcineurin-nuclear factor of activated T-cells.
    Molkentin JD
    Circ Res; 2013 Jun; 113(1):16-9. PubMed ID: 23788503
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Normalization of the calcineurin pathway underlies the regression of hypertensive hypertrophy induced by Na+/H+ exchanger-1 (NHE-1) inhibition.
    Ennis IL; Garciarena CD; Escudero EM; Pérez NG; Dulce RA; Camilión de Hurtado MC; Cingolani HE
    Can J Physiol Pharmacol; 2007; 85(3-4):301-10. PubMed ID: 17612638
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Calcineurin signaling in human cardiac hypertrophy.
    Williams RS
    Circulation; 2002 May; 105(19):2242-3. PubMed ID: 12010903
    [No Abstract]   [Full Text] [Related]  

  • 57. Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy.
    Lim HW; De Windt LJ; Steinberg L; Taigen T; Witt SA; Kimball TR; Molkentin JD
    Circulation; 2000 May; 101(20):2431-7. PubMed ID: 10821822
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peroxisome proliferator-activated receptor gamma coactivator 1 alpha protects cardiomyocytes from hypertrophy by suppressing calcineurin-nuclear factor of activated T cells c4 signaling pathway.
    Liu XP; Gao H; Huang XY; Chen YF; Feng XJ; He YH; Li ZM; Liu PQ
    Transl Res; 2015 Nov; 166(5):459-473.e3. PubMed ID: 26118953
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
    Dai H; Jia G; Liu X; Liu Z; Wang H
    Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
    Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
    Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.